Raw material testing will remain the foundation of cell and gene therapy (CGT) sector quality control strategies for the foreseeable future, according to new analysis, which shows the industry still ...
Austin, May 15, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Viral Inactivation Market was valued at USD 0.72 Billion in 2025 and is expected to reach USD 2.27 Billion by 2035, growing at a ...
Blood transfusion remains a life-saving intervention but carries inherent risks of transmitting viral pathogens and fostering complex co-infection scenarios. Beyond well-known agents such as HIV, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results